期刊簡介 | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | ONCOLOGY REPORTS LetPub Score 5.2
50 ratings
Rate
Reputation 4.0 Influence 5.4 Speed 9.1 | ||||||||||||||||||||
期刊簡稱 | ONCOL REP | ||||||||||||||||||||
ISSN | 1021-335X | ||||||||||||||||||||
E-ISSN | 1791-2431 | ||||||||||||||||||||
h-index | 84 | ||||||||||||||||||||
CiteScore |
| ||||||||||||||||||||
自引率 (2023-2024) | 2.60%自引率趨勢 | ||||||||||||||||||||
掲載範囲 |
| ||||||||||||||||||||
官方網站 | http://www.spandidos-publications.com/or | ||||||||||||||||||||
在線稿件提交 | http://www.spandidos-publications.com/login | ||||||||||||||||||||
開放訪問 | No | ||||||||||||||||||||
出版商 | Spandidos Publications | ||||||||||||||||||||
主題領域 | 医学 | ||||||||||||||||||||
出版國/地區 | GREECE | ||||||||||||||||||||
發行頻率 | 月刊 | ||||||||||||||||||||
創刊年 | 1994 | ||||||||||||||||||||
每年文章數 | 162每年文章數趨勢 | ||||||||||||||||||||
黃金OA百分比 | 75.70% | ||||||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q2
| ||||||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Science Citation Index Expanded | ||||||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1021-335X%5BISSN%5D | ||||||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: Average 5.5 Month(s) | ||||||||||||||||||||
競爭力 * | 來自作者的數據: About 54.23% | ||||||||||||||||||||
參考鏈接 |
| ||||||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 2 3 4 5 6 7 下一頁 末頁 (頁 | |
[ONCOLOGY REPORTS] 的評論 | 撰寫評論 |
作者: GaEs 領域: 医学 審稿時間: 2.0 month(s) 結果: 拒稿 撰寫評論 |
2024-09-25 17:33:10 評論於 Trash journals, revised back and forth many times, and finally rejected for ethical reasons. They didn't say it earlier. Friends in China, be cautious about submitting. We can't solve the ethical issues. Sigh. The review process feels okay speed-wise. Everything else is garbage!!!! Blacklisted for life!(0) 讚! | GaEs |
作者: 太玄博雅 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-08-27 15:49:15 評論於 I will not submit this magazine again in the future. In the beginning, I asked about your ethical handling methods and also provided an ethics review book, including how to euthanize animals, but did not mention any ethical issues. After nearly a month, I asked which country's standards euthanasia should comply with - the United States, Europe, or the United Kingdom. I wrote the standards for the United States. Then it was rejected, saying that excessive inhalation anesthesia with isoflurane is not allowed. If you want to reject it, reject it early to avoid wasting others' time.(0) 讚! | 太玄博雅 |
作者: 一只素芬呀 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-07-08 11:31:01 評論於 May I ask if this magazine accepts case reports?(0) 讚! | 一只素芬呀 |
作者: star 領域: 医学 審稿時間: 4.0 month(s) 結果: 拒稿 撰寫評論 |
2024-06-28 17:51:37 評論於 This magazine is so unreliable. After revising it five times back and forth, I felt there were no major issues. However, after the final revision, they said the ethical proof provided did not meet the requirements and rejected it without allowing any rebuttal. I wrote an email to ask what a standard ethical proof is and if they could provide a template for reference, as not all ethical proofs are the same. They replied directly that the submission was rejected, and then there was no further communication. It's a waste of time and the experimental results I supplemented were in vain.(0) 讚! | star |
作者: Lucky 領域: 生物学 審稿時間: 4.0 month(s) 結果: 修改後接受 撰寫評論 |
2024-06-25 16:48:03 評論於 The review process is quite slow, but as long as you write seriously, experts will provide very good opinions. Do not have a lucky psychology. If you feel that there is a problem with any aspect of your writing, you must make timely corrections. Otherwise, the reviewer will definitely find it, which will waste your time.(1) 讚! | Lucky |
作者: 努力啊大情韵 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-05-21 10:02:23 評論於 Whether in editing or external audit, only "under review" is displayed(0) 讚! | 努力啊大情韵 |
作者: 努力啊大情韵 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-05-21 09:25:01 評論於 Just recently invested, the progress is quite fast(0) 讚! | 努力啊大情韵 |
作者: 努力啊大情韵 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-04-15 19:31:52 評論於 Do you have any feedback on the following paragraph?(0) 讚! | 努力啊大情韵 |
作者: 暗月寺初曼 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-01-26 09:45:19 評論於 I also want to know(0) 讚! | 暗月寺初曼 |
作者: 暗月寺初曼 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-01-26 08:29:35 評論於 I also want to know(0) 讚! | 暗月寺初曼 |
作者: 萦思桑 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-01-10 21:13:04 評論於 What happened later?(0) 讚! | 萦思桑 |
作者: 澄静琪航 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-09-07 21:02:35 評論於 Please translate the following paragraph into English and Japanese, and title them as ":" and ":"(0) 讚! | 澄静琪航 |
作者: 飞鸿郎 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-08-01 13:14:58 評論於 I also want to know the answer to this question. Does "Under review" mean it has been submitted for review?(0) 讚! | 飞鸿郎 |
作者: 飞鸿郎 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-07-06 18:43:49 評論於 Research focus: Tumor Experience Sharing: How long does the editing under review typically last?(0) 讚! | 飞鸿郎 |
作者: 极乐明煦 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-06-07 09:27:29 評論於 Submission success rate: 50.0 Experience sharing: Is there a difference between "Under review" and "Under Review" in this magazine? Is the former indicating editorial review and the latter indicating external review?(0) 讚! | 极乐明煦 |
作者: 五河东亚 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-06-05 16:21:12 評論於 Do you need to upload the WB raw data?(0) 讚! | 五河东亚 |
作者: 五河东亚 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-06-05 13:35:56 評論於 Do you need to upload the original data of WB?(0) 讚! | 五河东亚 |
作者: 文柏姑娘 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-05-11 23:12:32 評論於 I wanted to ask, how did it go in the end? Have you finished editing?(0) 讚! | 文柏姑娘 |
作者: 孤云芷珊 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-03-27 11:00:11 評論於 To resize and adjust the resolution of images using the PS software(0) 讚! | 孤云芷珊 |
作者: 通背天容 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-03-17 23:35:36 評論於 2300 euros(0) 讚! | 通背天容 |
作者: 魔都玉巧 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-02-01 23:34:07 評論於 Could you please help me? I submitted to International Journal of Oncology and received revisions after over a month. The opinions of the reviewers were positive, but they suggested transferring my submission to Oncology Reports. After making the revisions and resubmitting, the editor responded the next day. They addressed the issues raised by the reviewers and also requested information on ethics and informed consent. Does this mean they are interested in my submission? Will it be sent back to the reviewers again? Thank you(0) 讚! | 魔都玉巧 |
作者: 魔都玉巧 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-01-31 16:34:37 評論於 This magazine was included in the Chinese Academy of Sciences' warning list in 2020, removed from the warning list in 2021, and has been removed again on January 31, 2023. Can this magazine be safely submitted for publication?(0) 讚! | 魔都玉巧 |
作者: 筑阳笑春 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-01-03 12:23:11 評論於 How long does it take to receive proof after the order?(0) 讚! | 筑阳笑春 |
作者: 杨家建同 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-12-17 14:59:53 評論於 I'm waiting too, 10.04 under review and still no news, getting anxious(0) 讚! | 杨家建同 |
作者: 金山沛容 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-11-30 08:25:40 評論於 Have you voted?(0) 讚! | 金山沛容 |
首頁 上一頁 1 2 3 4 5 6 7 下一頁 末頁 (頁 |
Contact us